CPT1A and nonpapillary renal cell carcinoma: Emerging work also has suggested that FAO reduction by CPT1A downregulation [11] or lipid-deposition process enhancement by PLIN2 [9], both mediated by mutated VHL and HIFs, contributes to the high lipid content in ccRCC.